← 返回

单细胞测序揭示胰腺癌 TIL(肿瘤浸润淋巴细胞)状态的演变轨迹

英文原题:Single-Cell Sequencing Reveals Trajectory of Tumor-Infiltrating Lymphocyte States in Pancreatic Cancer.

查看英文原题

Single-Cell Sequencing Reveals Trajectory of Tumor-Infiltrating Lymphocyte States in Pancreatic Cancer.

PubMed 2022/10/05(内容时间) Cancer Discov Q1 · IF 29.5(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

胰腺导管腺癌(PDAC)有效治疗手段很少。免疫治疗虽是有吸引力的替代策略,但由于对PDACTIL(肿瘤浸润淋巴细胞)图景了解不足,应用仍面临挑战。本研究对57份PDAC样本、22份未受累/正常样本及培养TIL中的8万余个T细胞进行单细胞转录组和T细胞受体分析,建立T细胞亚群参考图谱。数据揭示20种细胞状态及TIL群体的异质性分布。根据T细胞受体克隆型共享,CD8+ TIL中存在推定的GZMK+过渡性亚群;细胞状态轨迹分析显示,该群与GZMB+PRF1+细胞毒性亚群及CXCL13+功能障碍亚群相似。统计分析提示,某些TIL状态(如功能障碍和抑制性亚群)常同时出现。最后,培养TIL分析显示,效应细胞群中的高频克隆更易扩增。这些数据为理解PDAC TIL图景提供框架,可支持未来将TIL用于PDAC免疫治疗。 意义:提高PDAC免疫治疗疗效亟需深入了解其TIL图景。本研究建立PDAC TIL亚群及其相互关系的参考图谱,为未来免疫治疗工作奠定基础。本文亦在“本期亮点”栏目介绍,见2221页。

展开英文摘要原文

UNLABELLED: Pancreatic ductal adenocarcinoma (PDAC) has few effective treatments. Immunotherapy, an attractive alternative strategy, remains challenging with the lack of knowledge on the tumor-infiltrating lymphocyte (TIL) landscape in PDAC. To generate a reference of T-cell subpopulations, we profiled 80,000 T cells from 57 PDAC samples, 22 uninvolved/normal samples, and cultured TIL using single-cell transcriptomic and T-cell receptor analysis.

These data revealed 20 cell states and heterogeneous distributions of TIL populations. The CD8+ TIL contained a putative transitional GZMK+ population based on T-cell receptor clonotype sharing, and cell-state trajectory analysis showed similarity to a GZMB+PRF1+ cytotoxic and a CXCL13+ dysfunctional population. Statistical analysis suggested that certain TIL states, such as dysfunctional and inhibitory populations, often occurred together.

Finally, analysis of cultured TIL revealed that high-frequency clones from effector populations were preferentially expanded. These data provide a framework for understanding the PDAC TIL landscape for future TIL use in immunotherapy for PDAC. SIGNIFICANCE: To improve the efficacy of immunotherapy in PDAC, there is a great need to understand the PDAC TIL landscape.

This study represents a reference of PDAC TIL subpopulations and their relationships and provides a foundation upon which to base future immunotherapeutic efforts. This article is highlighted in the In This Issue feature, p. 2221.

论文信息

作者
Schalck A、Sakellariou-Thompson D、Forget MA、Sei E、Hughes TG、Reuben A、Bai S、Hu M
第一作者单位
Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas.United States
通讯作者单位
Department of Biologics Development, The University of Texas MD Anderson Cancer Center, Houston, Texas.United States
文献类型
非美国政府资助研究 · 美国 NIH 资助研究
期刊
Cancer discovery2022 Oct 5
原文标识
PubMed 35849783 · DOI 10.1158/2159-8290.CD-21-1248